Evolent Health Inc. (NYSE:EVH)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as $26.84 and last traded at $26.80, with a volume of 68,822 shares trading hands. The stock had previously closed at $26.47.

EVH has been the subject of a number of analyst reports. Zacks Investment Research lowered shares of Evolent Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 4th. Canaccord Genuity restated a “buy” rating on shares of Evolent Health in a research report on Friday, May 13th. FBR & Co reiterated a “buy” rating on shares of Evolent Health in a research report on Saturday, May 14th. Leerink Swann reiterated a “buy” rating and set a $20.00 target price on shares of Evolent Health in a research report on Monday, May 16th. Finally, Jefferies Group began coverage on shares of Evolent Health in a research report on Tuesday, July 26th. They set a “buy” rating and a $28.00 target price for the company. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $22.50.

The firm’s market cap is $1.10 billion. The company has a 50-day moving average of $22.29 and a 200-day moving average of $14.47.

Evolent Health (NYSE:EVH) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.12) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.16) by $0.04. The business had revenue of $56.50 million for the quarter, compared to analysts’ expectations of $51.96 million. Evolent Health’s revenue for the quarter was up 443.3% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.95) EPS. On average, analysts predict that Evolent Health Inc. will post ($0.55) EPS for the current fiscal year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group raised its stake in shares of Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Evolent Health worth $4,310,000 as of its most recent filing with the SEC.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.